Non-invasive detection of coronary stent complications using a new device
Official title: First-in-human Study to Assess the Clinical Feasibility, Safety, and Performance of the α Prototype of the NIMBLE System for Diagnosing Complications in Intracoronary Stents. NIMBLE-I Study.
Run by Nimble Diagnostics S.L. · NCT06968858 · Data updated 2026-11-12
This study is testing a new non-invasive device to see if it can safely detect problems with coronary stents in patients who need heart tests.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Nimble Diagnostics S.L. Industry-sponsored |
| Locations | 1 site (Badalona, Catalonia) |
| Status | Recruiting |
| Started | September 12, 2024 |
| Main results expected | September 2025 |
| Study ends | October 2025 |
| Registry record updated | May 13, 2025 |
| Trial ID | NCT06968858 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients who have had one or more coronary stents implanted and are experiencing symptoms suggestive of stent failure.
✕Probably not a fit
Patients with implanted electronic devices like pacemakers or those unable to provide informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The NIMBLE-I study is a pilot clinical trial evaluating the feasibility and safety of a novel non-invasive device called the NIMBLE system for detecting complications related to coronary stents, particularly in-stent restenosis. Conducted at the Hospital Germans Trias i Pujol in Spain, this single-center trial aims to provide a safer alternative to traditional invasive diagnostic methods. The NIMBLE system utilizes microwave interferometry to monitor changes in the stent environment without the need for ionizing radiation or invasive procedures. The study will assess the usability and preliminary performance of this innovative approach in patients scheduled for coronary angiography.
Why it matters
Potential benefit: If successful, this device could significantly reduce the need for invasive procedures in monitoring coronary stent complications, improving patient safety and comfort.
How similar studies have gone: While the approach of using non-invasive monitoring for stent complications is innovative, similar studies have shown promise in other non-invasive diagnostic technologies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Prior implantation of one or more coronary stents * Clinical symptoms suggestive of stent failure (e.g., chest pain, ischemic ECG changes) * Undergoing scheduled coronary angiography * Informed consent provided Exclusion Criteria: * Pregnancy * Implanted electronic devices (e.g., pacemakers) that may interfere with MWI * Inability to provide consent * Chest conditions preventing correct positioning of the device
Where it's running
-
Hospital Universitari Germans Trias i Pujol
Badalona, Catalonia, Spain Recruiting
Study contacts
- Principal investigator: Oriol Rodriguez-Leor, MD, PhD — Germans Trias i Pujol Hospital
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
OPN Balloon Use for Recanalization of Calcified Coronary Lesions
This registry tests how the SIS-OPN balloon is used in real-world patients with calcified coronary disease who have undergone PCI in North America.
-
Intravascular imaging–guided versus angiography-guided repeat PCI for drug-eluting stent in-stent restenosis
This trial tests whether using intravascular imaging (primarily IVUS) to guide repeat PCI gives better clinical and angiographic results than angiography alone for people with drug-eluting stent in-stent restenosis.
-
Using intra-nasal ketorolac to relieve pain from ureteral stents after ureteroscopy
This study is testing whether a nasal spray of ketorolac can help relieve pain better than oral diclofenac for patients with ureteral stents after surgery.
-
Evaluating a new drug-coated balloon for treating coronary artery disease
This study is testing a new drug-coated balloon to see if it can safely and effectively treat people with coronary artery disease who have had previous stents placed.
-
Comparing anti-inflammatory therapies for recurrent in-stent restenosis
This study is testing whether adding low-dose colchicine or prednisone to standard drug therapy can help people with recurrent in-stent restenosis feel better and avoid heart problems after coronary treatment.
-
Treatment of In-Stent Restenosis with MagicTouch Sirolimus-Coated Balloon
This study is testing whether the MagicTouch sirolimus-coated balloon can help people with in-stent restenosis feel better compared to standard balloon treatment after having a drug-eluting stent placed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.